Newstral
Article
Aapnewsarchive.com on 2018-04-25 14:41
Stronger pound weighs on revenues at drugmaker GSK
Related news
- ADrugmaker GSK reviewing its R&D programs under new CEOapnewsarchive.com
- Drugmaker GSK profit rockets on consumer health spinofftimesofmalta.com
- Drugmaker GSK buys US cancer firm for $1.9 billiontimesofmalta.com
- NGSK buying cancer drugmaker Tesaro in $5.1 billion dealnypost.com
- Drugmaker GSK to split after striking Pfizer consumer health dealCBC
- FGSK stresses ‘confidence’ as revenues beat expectationsft.com
- Drugmaker GSK sees earnings growth returning in 2016abc3340.com
- Vermont revenues coming in stronger than expectedWCAX
- FGSK and CureVac’s second vaccine yields stronger responseft.com
- FGSK to create 5,000 jobs as UK drugmaker plans £400m investment in life sciences campusft.com
- FHedge fund Elliott builds up multibillion-pound stake in GSKft.com
- HBritish Drugmaker GSK to Collaborate With CEPI in Effort to Develop Coronavirus Vaccinehamodia.com
- MFTSE 100 closes in the red as stronger pound weighsmarketwatch.com
- GSK taps new CEObizjournals.com
- AGSK cheers investors with asthma drug sales, big dividendapnewsarchive.com
- GSK, Pfizer to merge their healthcare divisionsMerced Sun-Star
- GSK, Pfizer to merge health care divisionsdailyherald.com
- GSK sees earnings rise amid good demand for vaccinesthenewstribune.com
- HGSK Warns Profits to Be Hit by Generic Drugs Competitionhamodia.com